药物对比
Fremanezumab vs Rimegepant
Fremanezumab (Ajovy) vs Rimegepant (Nurtec): CGRP migraine drugs compared. Injection vs oral, preventive vs acute/preventive use, efficacy and safety.
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating CGRP-targeted migraine therapies, choosing between a preventive injectable monoclonal antibody and an oral gepant for acute or preventive use.
结论
Fremanezumab and Rimegepant both effectively target CGRP pathways for migraine but differ in route, dosing, and indications, so the better option is highly individualized.
全部药物对比